Integrins as receptors give insight into rotavirus and diarrheaJuly 01, 2008Eleven years ago, Dr. Mary Estes of Baylor College of Medicine and her colleagues discovered the first viral enterotoxin, rotavirus NSP4, a toxic protein that affects the intestines, causing diarrhea. The next step was to find the cellular receptor on intestinal cells through which the enterotoxin interacts to cause diarrhea. "We knew that identifying the receptor might not be straightforward," said the professor of molecular virology and microbiology at BCM. In a report online in the Proceedings of the National Academy of Sciences, Estes and her colleagues describe two receptors for the enterotoxin, both of them integrins.
The two, integrin alpha1 beta1 and integrin alpha2 beta1, are members of a class of molecules that are involved in attaching cells to other cells and to the extracellular matrix (a part of tissue that is not part of any cell). Integrins also are involved in transforming or translating cell signals. In looking for the receptor, Estes and her colleagues also learned more about the enterotoxin itself. "It's a new ligand for binding to integrins," she said. "It begins to give us an understanding of how the enterotoxin works in the intestine. Two different domains of the enterotoxin are involved in this interaction. One domain is for binding and the other domain is for signaling through the receptor." She said she hopes to study the signaling aspect of the enterotoxin more closely because it could hold the clue to the mechanism of induction of diarrheal disease. "There may be ways to block the interaction between the enterotoxin and the receptor to treat diarrheal disease," said Estes, who is also director of the Texas Medical Center Digestive Diseases Center. Rotavirus is one of the most common causes of diarrhea, resulting in approximately 3 million cases of diarrhea and 55,000 hospitalizations for diarrhea and dehydration in children under the age of 5 each year in the United States alone. Worldwide, it causes nearly half a million deaths each year. Finding out how rotavirus causes diarrhea and looking for ways to block it is a major aim of Estes' research. Baylor College of Medicine Science News and Science Current Events Tag Cloud This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size. Technology Embryonic Stem Cell Pollution Dolphins Fatty Acid Magnetic Field Nervous System Caesarean Neck Cancer Cell Death Bisphenol A Nanoparticle Prion Chromosomes Neurodegenerative Disease Leptin Salmon Probiotics Smoking Electricity Sexual Abuse Quasar Attractiveness Phytophthora Ulcerative Colitis
See More: Science News Tags | |||||||||||||||||||||
|
Related Diarrhea Current Events and Diarrhea News Articles Mayo Clinic study finds celiac disease 4 times more common than in 1950s Celiac disease, an immune system reaction to gluten in the diet, is over four times more common today than it was 50 years ago, according to findings of a Mayo Clinic study published this month in the journal Gastroenterology. Antibiotics take toll on beneficial microbes in gut It's common knowledge that a protective navy of bacteria normally floats in our intestinal tracts. Antibiotics at least temporarily disturb the normal balance. New images may improve vaccine design for deadly rotavirus Howard Hughes Medical Institute researchers are reporting the first detailed molecular snapshots of a deadly gastrointestinal virus as it is caught in the grasp of an immune system molecule with the capacity to destroy it. Newly discovered reactions from an old drug may lead to new antibiotics A mineral found at health food stores could be the key to developing a new line of antibiotics for bacteria that commonly cause diarrhea, tooth decay and, in some severe cases, death. Common autism medication is ineffective for repetitive behaviors, study finds Citalopram (Celexa), a medication commonly prescribed to children with autism spectrum disorders (ASD), was no more effective than a placebo at reducing repetitive behaviors. Citalopram no better than placebo treatment for children with autism spectrum disorders Citalopram, a medication commonly prescribed to children with autism spectrum disorders (ASD), was no more effective than a placebo at reducing repetitive behaviors. Vandetanib shows clinical benefit when combined with docetaxel for lung cancer When combined with standard chemotherapy, an international Phase III trial has shown that the oral targeted therapy vandetanib improves progression-free survival for patients with advanced non-small cell lung cancer. Small molecule inhibitor shows promise in trastuzumab-resistant metastatic breast cancer Fox Chase Cancer Center researchers report that a combination of trastuzumab and neratinib (HKI-272) a novel small molecule inhibitor of the HER2 receptor (ErbB2) appears active in women with HER2-positive metastatic breast cancer who have progressed on previous trastuzumab based therapies. Chronic diarrhea unresponsive to conventional medication: Are you taking lansoprazole? Lansoprazole is a proton pump inhibitor which powerfully suppresses gastric acid production and is widely prescribed for chronic use in gastroesophageal reflux disease. Dengue fever costs billions in health care, lost productivity and absenteeism Researchers at Brandeis, in collaboration with several other institutions worldwide, have pinpointed for the first time the multi-country economic costs of dengue fever, the endemic and epidemic mosquito-borne illness that is a rapidly growing public health problem in tropical and sub-tropical countries. More Diarrhea Current Events and Diarrhea News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||